Effects of switching from dipeptidyl peptidase 4 inhibitors to oral semaglutide on oxidative stress and glycemic variability in patients with type 2 diabetes: an open-label, prospective, randomized, multicenter, parallel-group comparison study

Authors

Hiroki Yokoyama (ORCID: https://orcid.org/0000-0003-1602-4050)
Hiroaki Seino (ORCID: https://orcid.org/0000-0003-4690-9722)
Yo Kohata
Michishige Terasaki (ORCID: https://orcid.org/0000-0002-7405-7419)
Sho‐ichi Yamagishi (ORCID: https://orcid.org/0000-0003-0102-0823)
Tomoyasu Fukui (ORCID: https://orcid.org/0000-0002-8535-008X)
Makoto Ohara (ORCID: https://orcid.org/0000-0002-6137-5493)
Noriyuki Takahashi (ORCID: https://orcid.org/0000-0003-1982-7019)
Yusaku Mori (ORCID: https://orcid.org/0000-0002-1734-0605)
Shunichiro Irie
Tomoki Fujikawa

Institutions

SHOWA Medical University (JP)
Hoshigaoka Medical Center (JP)
Tokatsu Hospital (JP)
Koriyama Institute of Health Sciences (JP)

Publication Details

Journal: Diabetology & Metabolic Syndrome
Published: 2025-04-14
DOI: https://doi.org/10.1186/s13098-025-01691-y
Primary Topic: Diabetes Treatment and Management
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Effects of switching from dipeptidyl peptidase 4 inhibitors to oral semaglutide on oxidative stress and glycemic variability in patients with type 2 diabetes: an open-label, prospective, randomized, multicenter, parallel-group comparison study

Hiroki Yokoyama, Hiroaki Seino, Yo Kohata, Michishige Terasaki et al.

Apr 14, 2025

Diabetology & Metabolic Syndrome

Diabetes Treatment and Management

article

Effects of switching from dipeptidyl peptidase 4 inhibitors to oral semaglutide on oxidative stress and glycemic variability in patients with type 2 diabetes: an open-label, prospective, randomized, multicenter, parallel-group comparison study

Hiroki Yokoyama, Hiroaki Seino, Yo Kohata, Michishige Terasaki, Sho‐ichi Yamagishi, Tomoyasu Fukui, Makoto Ohara, Noriyuki Takahashi, Yusaku Mori, Shunichiro Irie, Tomoki Fujikawa

April 14, 2025article en

Abstract

No abstract available for this paper.

Diabetology & Metabolic SyndromeVol. 17(1)

SHOWA Medical University (JP), Hoshigaoka Medical Center (JP), Tokatsu Hospital (JP), Koriyama Institute of Health Sciences (JP)

Openalex Percentile: Top 90%

Diabetes Treatment and Management

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Effects of switching from dipeptidyl peptidase 4 inhibitors to oral semaglutide on oxidative stress and glycemic variability in patients with type 2 diabetes: an open-label, prospective, randomized, multicenter, parallel-group comparison study — Hiroki Yokoyama, Hiroaki Seino, et al. · Diabetology & Metabolic Syndrome (2025) | TGRS Research Map | TGRS